Cargando…

Immune transcriptomes of highly exposed SARSCoV-2 asymptomatic seropositive versus seronegative individuals from the Ischgl community

Mostrar otras versiones (2)

To investigate prevalence of ongoing activation of inflammation following asymptomatic SARS-CoV-2 infection we characterized immune cell transcriptomes from 43 asymptomatic seropositive and 52 highly exposed seronegative individuals with few underlying health issues following a community superspread...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Hye Kyung, Knabl, Ludwig, Pipperger, Lisa, Volland, Andre, Furth, Priscilla, Kang, Keunsoo, Smith, Harold, Bellmann, Romuald, Bernhard, Christina, Kaiser, Norbert, Gänzer, Hannes, Ströhle, Mathias, Walser, Andreas, Von Laer, Dorothee, Hennighausen, Lothar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Journal Experts 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523134/ https://www.ncbi.nlm.nih.gov/pubmed/32995765 http://dx.doi.org/10.21203/rs.3.rs-69657/v1

Ejemplares similares

Immune transcriptomes of highly exposed SARS-CoV-2 asymptomatic seropositive versus seronegative individuals from the Ischgl community
por: Lee, Hye Kyung, et al.
Publicado: (2020)

Immune transcriptomes of highly exposed SARS-CoV-2 asymptomatic seropositive versus seronegative individuals from the Ischgl community
por: Lee, Hye Kyung, et al.
Publicado: (2021)

High SARS-CoV-2 seroprevalence in children and adults in the Austrian ski resort of Ischgl
por: Knabl, Ludwig, et al.
Publicado: (2021)

Persistence of immunity to SARS-CoV-2 over time in the ski resort Ischgl
por: Borena, Wegene, et al.
Publicado: (2021)

Robust immune response to the BNT162b mRNA vaccine in an elderly population vaccinated 15 months after recovery from COVID-19
por: Lee, Hye Kyung, et al.
Publicado: (2021)

Estimating seroprevalence of SARS-CoV-2 antibodies using three self-reported symptoms: development of a prediction model based on data from Ischgl, Austria
por: Lehmann, Jens, et al.
Publicado: (2021)

Limited cross-variant immune response from SARS-CoV-2 Omicron BA.2 in naïve but not previously infected outpatients
por: Lee, Hye Kyung, et al.
Publicado: (2022)

Limited cross-variant immune response from SARS-CoV-2 Omicron BA.2 in naïve but not previously infected outpatients
por: Lee, Hye Kyung, et al.
Publicado: (2022)

Immune transcriptomes from hospitalized patients infected with the SARS-CoV-2 variants B.1.1.7 and B.1.1.7 carrying the E484K escape mutation
por: Lee, Hye Kyung, et al.
Publicado: (2021)

Immune transcriptome analysis of COVID-19 patients infected with SARS-CoV-2 variants carrying the E484K escape mutation identifies a distinct gene module
por: Lee, Hye Kyung, et al.
Publicado: (2022)

Impact of BNT162b First Vaccination on the Immune Transcriptome of Elderly Patients Infected with the B.1.351 SARS-CoV-2 Variant
por: Knabl, Ludwig, et al.
Publicado: (2021)

Is SARSCoV-2 nasopharyngeal swab still a gold standard in children?
por: Marino, Silvia, et al.
Publicado: (2020)

Impact of liver enzymes on SARSCoV-2 infection and on the severity of clinical disease
por: Servín-Caamaño, A., et al.
Publicado: (2020)

BNT162b2 vaccination enhances interferon-JAK-STAT-regulated antiviral programs in COVID-19 patients infected with the SARS-CoV-2 Beta variant
por: Knabl, Ludwig, et al.
Publicado: (2022)

Impact of BNT162b first vaccination on the immune transcriptome of elderly patients infected with the B.1.351 SARS-CoV-2 variant
por: Knabl, Ludwig, et al.
Publicado: (2021)

Neutralization Profile after Recovery from SARS-CoV-2 Omicron Infection
por: Rössler, Annika, et al.
Publicado: (2022)

Exploring the acceptability of controlled human infection with SARSCoV2—a public consultation
por: Gbesemete, D., et al.
Publicado: (2020)

So much at stake: Ethical tradeoffs in accelerating SARSCoV-2 vaccine development
por: Grady, Christine, et al.
Publicado: (2020)

Aspartate aminotransferase as predictor of severity in SARSCoV-2 infection: linear regression model
por: Servín-Caamaño, A., et al.
Publicado: (2020)

SARSCoV-2 serostatus amongst vaccinated employees at a pediatric hospital system
por: Devaraj, Sridevi, et al.
Publicado: (2021)

Steroid therapy and antiviral treatment in SARSCoV-2 pneumonia: clinical contexts and indications
por: Torres, Antoni, et al.
Publicado: (2022)

Vaccination against SARSCoV-19 among psychiatric patients at the central Greek hospital
por: Anagnostaki, M. E., et al.
Publicado: (2023)

Prior Vaccination Exceeds Prior Infection in Eliciting Innate and Humoral Immune Responses in Omicron Infected Outpatients
por: Lee, Hye Kyung, et al.
Publicado: (2022)

mRNA vaccination in octogenarians 15 and 20 months after recovery from COVID-19 elicits robust immune and antibody responses that include Omicron
por: Lee, Hye Kyung, et al.
Publicado: (2022)

On the case report of Platypnea-orthodeoxia after SARSCoV-2 pneumonia plus historical notes
por: Corrêa, Paulo César Rodrigues Pinto
Publicado: (2020)

Anti-Rheumatic Drugs for the Fight Against the Novel Coronavirus Infection (SARSCoV-2): What is the Evidence?
por: Pelechas, Eleftherios, et al.
Publicado: (2020)

Early Identification of IgA Anti-SARSCoV-2 in Milk of Mother With COVID-19 Infection
por: Lebrão, Cibele Wolf, et al.
Publicado: (2020)

Indian association of medical microbiologists (IAMM) position paper on guidelines for COVID and SARSCoV2 infections
por: Ravi, V., et al.
Publicado: (2023)

Case report of a neonate with high viral SARSCoV-2 loads and long-term virus shedding
por: Slaats, Monique A.L.J., et al.
Publicado: (2020)

Central retinal artery occlusion after vaccination with whole virion inactivated SARSCoV- 2 vaccine Covaxin
por: Thakar, Meenakshi, et al.
Publicado: (2022)

495. De novo emergence of resistance mutations during treatment of SARSCoV-2 infection in immunocompromised patients
por: Johnson, Katherine, et al.
Publicado: (2023)

Heterologous ChAdOx1-BNT162b2 vaccination in Korean cohort induces robust immune and antibody responses that includes Omicron
por: Lee, Hye Kyung, et al.
Publicado: (2022)

Reduced sensitivity of antibody tests after omicron infection
por: Rössler, Annika, et al.
Publicado: (2023)

Nephrotic Syndrome Following ChAdOx1 nCoV-19 Vaccine Against SARScoV-2
por: Anupama, Y.J., et al.
Publicado: (2021)

BNT162b2 induced neutralizing and non-neutralizing antibody functions against SARSCoV-2 diminish with age
por: Bates, Timothy A., et al.
Publicado: (2022)

Evolución temporal de las variantes de SARSCoV-2 circulantes en el área sanitaria de Cádiz
por: Ibañez-López, Cristina, et al.
Publicado: (2023)

The impact of lockdown enforcement during the SARSCoV-2 pandemic on the timing of presentation and early outcomes of patients with ST-elevation myocardial infarction
por: Kobo, Ofer, et al.
Publicado: (2020)

Gastrointestinal tract diseases as a risk factor for SARSCoV2 rectal shedding? An Italian report on 10 COVID-19 patients
por: Patrì, Angela, et al.
Publicado: (2021)

Corrigendum: Neuro-PASC is characterized by enhanced CD4+ and diminished CD8+ T cell responses to SARSCoV-2 Nucleocapsid protein
por: Visvabharathy, Lavanya, et al.
Publicado: (2023)

445 Inflammation in normal COVID-19 airway due to inhibition of cystic fibrosis transmembrane conductance regulator signaling by the SARSCoV-2 Spike protein
por: Caohuy, H., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b0ethh2gs72v5bdrm1j7atu3rq